Cigna initiated with a Neutral at Cantor Fitzgerald

Cantor Fitzgerald analyst Sarah James initiated coverage of Cigna with a Neutral rating and $285 price target. The company’s valuation gets discounted by investors for long-term growth rate peer comparisons but doesn’t get credit for being a hedge against market risk over the next 12-24 months, the analyst tells investors in a research note.